Celularity Stock Probability of Future Stock Price Finishing Over 18.46
| CELU Stock | USD 2.76 0.09 3.16% |
Celularity |
Celularity Target Price Odds to finish over 18.46
The tendency of Celularity Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 18.46 or more in 90 days |
| 2.76 | 90 days | 18.46 | close to zero percent |
Based on a normal probability distribution, the odds of Celularity to move over $ 18.46 or more in 90 days from now is close to zero percent (This Celularity probability density function shows the probability of Celularity Stock to fall within a particular range of prices over 90 days) . Probability of Celularity price to stay between its current price of $ 2.76 and $ 18.46 at the end of the 90-day period is about 41.04 .
Given the investment horizon of 90 days Celularity has a beta of 0.57 suggesting as returns on the market go up, Celularity average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Celularity will be expected to be much smaller as well. Additionally Celularity has an alpha of 0.6378, implying that it can generate a 0.64 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Celularity Price Density |
| Price |
Predictive Modules for Celularity
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Celularity. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Celularity Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Celularity is not an exception. The market had few large corrections towards the Celularity's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Celularity, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Celularity within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.64 | |
β | Beta against Dow Jones | 0.57 | |
σ | Overall volatility | 0.53 | |
Ir | Information ratio | 0.04 |
Celularity Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Celularity for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Celularity can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Celularity is way too risky over 90 days horizon | |
| Celularity appears to be risky and price may revert if volatility continues | |
| Celularity has a very high chance of going through financial distress in the upcoming years | |
| Celularity currently holds 39.24 M in liabilities with Debt to Equity (D/E) ratio of 0.41, which is about average as compared to similar companies. Celularity has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Celularity's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 22.77 M. Net Loss for the year was (196.29 M) with loss before overhead, payroll, taxes, and interest of (1.69 M). | |
| Celularity currently holds about 42.65 M in cash with (38.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| Roughly 50.0% of Celularity shares are held by company insiders | |
| Latest headline from news.google.com: Celularity Partners with Genting to Build 7.2B Market-Targeting Stem Cell Facility in Bali CELU Stock News - StockTitan |
Celularity Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Celularity Stock often depends not only on the future outlook of the current and potential Celularity's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Celularity's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 19.4 M |
Celularity Technical Analysis
Celularity's future price can be derived by breaking down and analyzing its technical indicators over time. Celularity Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Celularity. In general, you should focus on analyzing Celularity Stock price patterns and their correlations with different microeconomic environments and drivers.
Celularity Predictive Forecast Models
Celularity's time-series forecasting models is one of many Celularity's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Celularity's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Celularity
Checking the ongoing alerts about Celularity for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Celularity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Celularity is way too risky over 90 days horizon | |
| Celularity appears to be risky and price may revert if volatility continues | |
| Celularity has a very high chance of going through financial distress in the upcoming years | |
| Celularity currently holds 39.24 M in liabilities with Debt to Equity (D/E) ratio of 0.41, which is about average as compared to similar companies. Celularity has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Celularity's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 22.77 M. Net Loss for the year was (196.29 M) with loss before overhead, payroll, taxes, and interest of (1.69 M). | |
| Celularity currently holds about 42.65 M in cash with (38.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| Roughly 50.0% of Celularity shares are held by company insiders | |
| Latest headline from news.google.com: Celularity Partners with Genting to Build 7.2B Market-Targeting Stem Cell Facility in Bali CELU Stock News - StockTitan |
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.